Shanghai Gui Guo Assets Management Partnership
2
33M
2
1
- Stages of investment
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Shanghai. The venture was found in Asia in China.
The top amount of exits for fund were in 2018. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2014.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Silicon Valley China Venture Partners, Jinyuan Development Company. In the next rounds fund is usually obtained by Oceanic Partners, H&Q Asia Pacific.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Transportation, Industrial. Among the most popular portfolio startups of the fund, we may highlight Efficient Drivetrains. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Electric Vehicle (1)
- Automotive (1)
- Transportation (1)
- Industrial (1)
- Electronics (1) Show 5 more
- Investments by region
-
- China (1)
- United States (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 0.50
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| OriginCell | 30 May 2022 | Biotechnology, Medical Device, Medical, Biopharma | Early Stage Venture | 63M | Shandong, Zhangdian District, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.